Skip to main content
Clinical Trials/NCT06115200
NCT06115200
Not yet recruiting
Not Applicable

Norwegian Adult Mental Health Registry

Helse Stavanger HF0 sites150,000 target enrollmentJanuary 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
Helse Stavanger HF
Enrollment
150000
Primary Endpoint
Frequency of ICD-10 or ICD-11 diagnosis F00-F99
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

"The Norwegian Adult Mental Health Registry" (NAMHR) is a medical quality register collecting and systematizing data on patients and their treatment in specialist mental health care for adults in Norway. The main purpose is to create a documentation basis for quality assurance, evaluation, and improvement of assessment and treatment for patients who are offered treatment for mental disorders in the specialist health service. The register uses automatic data capture from various existing data sources. New patients are automatically included, but given the opportunity for reservations from the register without affecting their services and treatment.

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
December 31, 2030
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Residents in Norway aged 18 years or older assessed and granted right to treatment in specialized mental in- and out-patient settings

Exclusion Criteria

  • Persons who have reserved themselves against participation
  • Persons already included in more specialized register for mental disorder and/or treatment

Outcomes

Primary Outcomes

Frequency of ICD-10 or ICD-11 diagnosis F00-F99

Time Frame: Discharge defined as: date of discharge from any cause, assessed up to 60 months

International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) or ISD-11: Chapter V: Mental and behavioural disorders (F00-F99)Revision (ICD-10) WHO: Chapter V: Mental and behavioural disorders (F00-F99)

Patient Reported Outcome Measures (PROMs)

Time Frame: Six months after discharge

Percentage of subjects that experienced change in PROMs

Rate of overweight defined as BMI > 25 (body mass index)

Time Frame: Discharge defined as: date of discharge from any cause, assessed up to 60 months

Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters.

Level of blood pressure, both systolic and diastolic levels

Time Frame: Discharge defined as: date of discharge from any cause, assessed up to 60 months

Blood pressure varies between systolic and diastolic pressures after each heartbeat. Systolic pressure is peak (maximum) pressure in the arteries. Diastolic pressure is the lowest (minimum) pressure in the arteries.

Drug name and dosage from electronic medication management solutions

Time Frame: Six months after discharge from any cause, assessed up to 12 months

Frequency of psychotropic generic drug name and dosage

Bloodlevels of total cholesterol, LDL, HDL and Triglycerides

Time Frame: Discharge defined as: date of discharge from any cause, assessed up to 60 months

A lipid profile (lipid panel) is a set blood tests used to find abnormalities in blood lipids. The present panel will include: total cholesterol, LDL, HDL and Triglycerides.

Level of glycated haemoglobin (HbA1c)

Time Frame: Discharge defined as: date of discharge from any cause, assessed up to 60 months

Glycated hemoglobin is a form of hemoglobin chemically linked to sugar.

Similar Trials

Recruiting
Not Applicable
The National Register of Antipsychotic Medication in Pregnancy (NRAMP)PregnancyMental Disorders
NCT00686946The Alfred500
Recruiting
Not Applicable
AnovaOS Network Powered Patient RegistryInfectious DiseaseNeoplasmsDiseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)Endocrine, Nutritional and Metabolic Diseases (E00-E89)Mental and Behavioural DisordersDiseases of the Nervous SystemDiseases of the Eye and AdnexaDiseases of the Ear and Mastoid ProcessDiseases of the Circulatory SystemDiseases of the Respiratory SystemDiseases of the Digestive SystemDiseases of the Skin and Subcutaneous TissueDiseases of the Musculoskeletal System and Connective TissueDiseases of the Genitourinary SystemPregnancy, Childbirth and the PuerperiumCertain Conditions Originating in the Perinatal PeriodCongenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere ClassifiedInjury, Poisoning and Certain Other Consequences of External CausesExternal Causes of Morbidity and MortalityFactors Influencing Health Status and Contact With Health Services
NCT05013944Anova Enterprises, Inc100,000
Terminated
Not Applicable
A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.Non-valvular Atrial Fibrillation
NCT03715725Bayer70,000
Completed
Not Applicable
Bosentan Treatment of Digital Ulcers Related to Systemic SclerosisSystematic SclerosisDigital UlcerScleroderma
NCT02798055Elpen Pharmaceutical Co. Inc.148
Recruiting
Not Applicable
National Pregnancy Registry for Psychiatric MedicationsPregnant WomenPsychotropic Drugs
NCT01246765Massachusetts General Hospital5,000